GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) to treat chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.
Talk to your doctor to find out if GAMMAGARD LIQUID is right for you.
A therapy to improve neuromuscular disability and impairment in adult patients with CIDP.
Living with the symptoms of a chronic neurological disease can make even everyday activities a struggle.
GAMMAGARD LIQUID, a widely known IG therapy, may be used to help treat your CIDP to improve neuromuscular disability and impairment.
94% of people in the CIDP clinical study (17 out of 18 patients) experienced improvement on a measure of arm and leg disability after 6 months of treatment.*
*18 CIDP patients, who had relapsed in a previous study phase, received GAMMAGARD LIQUID treatment.
What makes GAMMAGARD LIQUID an established IVIG therapy?
How did CIDP patients tolerate GAMMAGARD LIQUID?
How can GAMMAGARD LIQUID fit into your schedule?
The GAMMAGARD LIQUID Treatment Brochure provides detailed facts of CIDP and how GAMMAGARD LIQUID may be a treatment option. Download this brochure to discuss with your doctor.
There’s an IG therapy option that’s infused subcutaneously with a flexible dosing schedule.
Talk to your doctor to determine which treatment could be right for you.